Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: Fecal Microbiota Transplant for Autobrewery Syndrome [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update notes a Phase 1 study from Massachusetts General Hospital evaluating fecal microbiota transplant for Auto-Brewery Syndrome (Gut Ferme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplant (fecal microbiota transplant)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Auto-Brewery Syndrome, Gut Fermentation Syndrome | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING